These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 18596596)

  • 21. Reproductive and hormonal risk factors for postmenopausal luminal, HER-2-overexpressing, and triple-negative breast cancer.
    Dizdar O; Aksoy S; Altundag K
    Cancer; 2009 Apr; 115(8):1802; author reply 1802-3. PubMed ID: 19165802
    [No Abstract]   [Full Text] [Related]  

  • 22. Physical activity and postmenopausal breast cancer: proposed biologic mechanisms and areas for future research.
    Neilson HK; Friedenreich CM; Brockton NT; Millikan RC
    Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):11-27. PubMed ID: 19124476
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Postmenopausal hormone therapy--an update. Benefit versus risk--important to identify women with increased breast cancer risk].
    von Schoultz B
    Lakartidningen; 2009 Aug 19-25; 106(34):2041-2. PubMed ID: 19769143
    [No Abstract]   [Full Text] [Related]  

  • 24. Polygenes, risk prediction, and targeted prevention of breast cancer.
    Jernström H
    N Engl J Med; 2008 Sep; 359(13):1407. PubMed ID: 18822457
    [No Abstract]   [Full Text] [Related]  

  • 25. Opportunities and strategies for breast cancer prevention through risk reduction.
    Mahoney MC; Bevers T; Linos E; Willett WC
    CA Cancer J Clin; 2008; 58(6):347-71. PubMed ID: 18981297
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The risk of getting breast cancer after hormonal replacement therapy for menopause is stopped].
    Jamin C; Madelenat P
    Gynecol Obstet Fertil; 2008 Nov; 36(11):1067-9. PubMed ID: 18951058
    [No Abstract]   [Full Text] [Related]  

  • 27. Diabetes and the menopause.
    Wedisinghe L; Perera M
    Maturitas; 2009 Jul; 63(3):200-3. PubMed ID: 19535207
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics.
    Ellis MJ; Tao Y; Luo J; A'Hern R; Evans DB; Bhatnagar AS; Chaudri Ross HA; von Kameke A; Miller WR; Smith I; Eiermann W; Dowsett M
    J Natl Cancer Inst; 2008 Oct; 100(19):1380-8. PubMed ID: 18812550
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of women at high risk for breast cancer.
    Arun B
    J Natl Compr Canc Netw; 2003 Jan; 1 Suppl 1():S71-7. PubMed ID: 19795579
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hormone replacement therapy and cardioprotection: a new dawn? A statement of the Study Group on Cardiovascular Disease in Women of the Italian Society of Cardiology on hormone replacement therapy in postmenopausal women.
    Rosano GM; Maffei S; Andreassi MG; Vitale C; Vassalle C; Gambacciani M; Stramba-Badiale M; Mercuro G
    J Cardiovasc Med (Hagerstown); 2009 Jan; 10(1):85-92. PubMed ID: 19145119
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Budget impact analysis of chemoprevention of breast cancer with tamoxifen and raloxifene among high-risk women in Japan.
    Kondo M; Hoshi SL; Toi M
    Jpn J Clin Oncol; 2009 Nov; 39(11):767-70. PubMed ID: 19656807
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hormone replacement therapy post Women's Health Initiative study: where do we stand?
    Calleja-Agius J; Brincat MP
    Curr Opin Obstet Gynecol; 2008 Dec; 20(6):513-8. PubMed ID: 18989125
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Breast cancer risk and history of being breast-fed.
    Ito S
    Epidemiology; 2009 Jan; 20(1):155. PubMed ID: 19234405
    [No Abstract]   [Full Text] [Related]  

  • 34. Re: Estrogen plus progestin therapy and breast cancer in recently postmenopausal women.
    Langer RD
    Am J Epidemiol; 2009 Mar; 169(6):784-5; author reply 785-6. PubMed ID: 19208722
    [No Abstract]   [Full Text] [Related]  

  • 35. Losing weight after menopause helps lower breast cancer risk.
    Mayo Clin Womens Healthsource; 2006 Dec; 10(12):3. PubMed ID: 17102789
    [No Abstract]   [Full Text] [Related]  

  • 36. Chemoprevention in postmenopausal women.
    Rastogi P
    Menopause; 2008; 15(4 Suppl):810-5. PubMed ID: 18596603
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risks and benefits of therapy with menopausal hormones versus selective estrogen-receptor modulators in peri- and postmenopausal women at increased breast cancer risk.
    Col NF; Chlebowski RT
    Menopause; 2008; 15(4 Suppl):804-9. PubMed ID: 18596602
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Did the decrease in use of menopausal hormone therapy induce a decrease in the incidence of breast cancer in France (and elsewhere)?].
    Ringa V; Fournier A
    Rev Epidemiol Sante Publique; 2008 Oct; 56(5):297-301. PubMed ID: 18947946
    [No Abstract]   [Full Text] [Related]  

  • 39. Menopause offers needed education.
    Menopause; 2008; 15(4 Suppl):777. PubMed ID: 18596596
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.